Newer Anticoagulants Can Be Used Off-Label

被引：0
|
作者：
Choi, Philip M. C. [1 ]
Hill, Michael D. [1 ]
机构：
[1] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary Stroke Program, Calgary, AB T2N 2T9, Canada
来源：
STROKE | 2014年 / 45卷 / 07期
关键词：
atrial fibrillation; heart; heart failure; stroke; transient ischemic attack; ATRIAL-FIBRILLATION; WARFARIN; DABIGATRAN; PREVENTION; ASPIRIN;
D O I：
10.1161/STROKEAHA.113.002694
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2154 / 2155
页数：2
相关论文
共 50 条
  • [41] Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia
    Schindewolf, Marc
    Steindl, Julia
    Beyer-Westendorf, Jan
    Schellong, Sebastian
    Dohmen, Pascal Maria
    Brachmann, Johannes
    Madlener, Katharina
    Poetzsch, Bernd
    Klamroth, Robert
    Hankowitz, Johannes
    Banik, Norbert
    Eberle, Sonja
    Mueller, Markus Michael
    Kropff, Stefan
    Lindhoff-Last, Edelgard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2636 - 2648
  • [42] Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi
    Robinson, Austin A.
    Trankle, Cory R.
    Eubanks, Grayson
    Schumann, Christopher
    Thompson, Paul
    Wallace, Ryan L.
    Gottiparthi, Shouri
    Ruth, Benjamin
    Kramer, Christopher M.
    Salerno, Michael
    Bilchick, Kenneth C.
    Deen, Cody
    Kontos, Michael C.
    Dent, John
    JAMA CARDIOLOGY, 2020, 5 (06) : 685 - 692
  • [43] Timing of Off-Label Dosing of Direct Oral Anticoagulants in Three Large Health Systems
    Herron, Grace C.
    DeCamillo, Deborah
    Kong, Xiaowen
    Haymart, Brian
    Kaatz, Scott
    Ellsworth, Stacy
    Ali, Mona A.
    Giuliano, Christopher
    Froehlich, James B.
    Barnes, Geoffrey D.
    THROMBOSIS AND HAEMOSTASIS, 2025, 125 (03) : 278 - 285
  • [44] WIDESPREAD OFF-LABEL USE OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH LEFT VENTRICULAR THROMBUS
    Shi, Boqun
    Wang, Haoyu
    Song, Chenxi
    Yin, Dong
    Wang, Hongjian
    Dou, Ke Fei
    Song, Weihua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1028 - 1028
  • [45] Off-label or off-limits?
    Ratner, Mark
    Gura, Trisha
    NATURE BIOTECHNOLOGY, 2008, 26 (08) : 867 - 875
  • [46] Discontinuation of off-label used antipsychotics; results and determinants for success or failure
    de Kuijper, G.
    JOURNAL OF APPLIED RESEARCH IN INTELLECTUAL DISABILITIES, 2018, 31 (04) : 546 - 546
  • [47] Safety Consequences of Off-Label Drugs Used for COVID-19
    Dasgupta, Nabarun
    DRUG SAFETY, 2021, 44 (04) : 399 - 402
  • [48] PUBLIC REIMBURSEMENT OF PRESCRIPTION DRUGS USED FOR OFF-LABEL INDICATIONS IN ONTARIO
    Rawson, Nigel S. B.
    Chhabra, Arpit
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2018, 25 (02): : E23 - E30
  • [49] Safety Consequences of Off-Label Drugs Used for COVID-19
    Nabarun Dasgupta
    Drug Safety, 2021, 44 : 399 - 402
  • [50] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
12345